Welcome to our dedicated page for Quaker Chemical SEC filings (Ticker: KWR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Quaker Houghton (NYSE: KWR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Quaker Houghton, also known in filings as Quaker Chemical Corporation, is a global industrial process fluids company serving steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking customers across the Americas, EMEA, and Asia/Pacific segments.
Through this page, readers can review core documents such as annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe the company’s industrial process fluids portfolio, geographic segments, risk factors, and management’s discussion and analysis of financial condition and results of operations. Current reports on Form 8-K, including those referenced in connection with quarterly earnings releases and leadership changes, provide timely updates on material events such as financial results, executive appointments, and other significant corporate developments.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand items such as net sales trends by segment, non-GAAP performance metrics like adjusted EBITDA, and the impact of acquisitions on Quaker Houghton’s financial profile. Real-time updates from the SEC’s EDGAR system ensure that new 10-K, 10-Q, and 8-K filings are available as they are posted.
Users can also access information related to executive and board changes reported under Item 5.02 of Form 8-K, as well as other governance and compensation disclosures that may appear in proxy and related filings. For investors analyzing KWR stock, this page offers a centralized view of Quaker Houghton’s official regulatory record, with AI tools that simplify complex financial and legal language into more accessible insights.
Quaker Chemical (KWR) reported higher quarterly sales but lower earnings. Q3 2025 net sales were $493.8 million, up from $462.3 million a year ago, driven by broad growth across Americas, EMEA and Asia/Pacific. Operating income was $46.6 million versus $51.7 million, and net income was $30.5 million with diluted EPS of $1.75, down from $1.81.
For the nine months, the company recorded a net loss of $23.2 million, primarily reflecting an $88.8 million non-cash goodwill impairment in EMEA recognized in Q2. Year-to-date restructuring and related charges were $31.1 million. Cash from operations was $89.9 million, while investing cash outflows of $193.0 million reflect acquisitions, notably Dipsol.
The April 2025 Dipsol acquisition totaled $185.6 million and contributed $20.6 million of sales in Q3 and $41.5 million year-to-date. To fund deals, debt increased: total debt was $875.2 million as of September 30, 2025, including $224.1 million drawn on the revolver. Quaker ended Q3 with $172.0 million in cash, declared a quarterly dividend of $0.508 per share, and continued share repurchases. Accumulated other comprehensive loss improved, aided by currency translation gains.
Quaker Chemical Corporation reported that it announced results of operations for the third quarter ended September 30, 2025. The company furnished a press release and related supplemental information to summarize its Q3 2025 performance and financial condition.
The materials are provided as Exhibits 99.1 (press release dated October 30, 2025) and 99.2 (supplemental information for the third quarter ended September 30, 2025). These exhibits offer the detailed financial and operating updates for the period.
Quaker Chemical (KWR) reported an insider equity award. The company’s SVP, CTO filed a Form 4 for the grant of 913 time‑based restricted stock units on 10/15/2025 under the Long‑Term Performance Incentive Plan.
The RSUs vest in three annual installments beginning on March 15, 2026. Each RSU represents a right to receive one share of KWR common stock, and dividend equivalent rights accrue when and as dividends are paid. Following the transaction, 913 derivative securities were beneficially owned, held directly.
Quaker Chemical (KWR) reported an insider equity grant. Officer Andre Frodl (VP, R&D–Metals & Metalworking) acquired 61 restricted stock units on 10/15/2025 under the Company’s Long-Term Performance Incentive Plan at a price of $0 per unit.
Each RSU represents the right to receive one share of KWR common stock. The RSUs vest in three annual installments beginning on March 15, 2026, and dividend equivalent rights accrue when and as dividends are paid. The holdings are reported as Direct (D) ownership.
Christine Procopio Johnson filed an Initial Statement of Beneficial Ownership (Form 3) reporting a 10/01/2025 event for Quaker Chemical Corp (KWR). She is identified as an officer with the title SVP, CTO. The filing states no securities are beneficially owned by the reporting person. The form was signed by an attorney-in-fact on 10/02/2025.
Andre Frodl, VP, R&D - Metals & Metalworking at Quaker Chemical Corp (KWR), filed an Initial Statement of Beneficial Ownership reporting direct ownership of 518 shares of KWR common stock and time‑based restricted stock units that represent 632 additional underlying shares. One RSU grant vests 50% on June 15, 2024 and 50% on December 15, 2025. Other RSU grants vest in three annual installments beginning March 15, 2024, March 15, 2025, and March 15, 2026, and dividend equivalent rights accrue as dividends are paid on KWR common stock. The Form 3 lists the reportable event date as 10/01/2025 and is signed by an attorney‑in‑fact.
Anna Ransley, Senior Vice President and Chief Digital & Information Officer of Quaker Chemical Corp (KWR), reported a Form 4 disclosing a transaction on 08/15/2025. The filing shows 372 shares of Quaker Chemical common stock were disposed (transaction code F) at a price of $135.4 per share. The filing explains these shares were surrendered to satisfy withholding tax upon vesting of restricted stock granted August 15, 2023 under the company's Long-Term Performance Incentive Plan. After the transaction, Ms. Ransley beneficially owned 1,959 shares directly. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
FAQ
What is the current stock price of Quaker Chemical (KWR)?
What is the market cap of Quaker Chemical (KWR)?
